- Rabkin, C.S., Devesa, S.S., Zahm, S.H. and Gail, M.H. (1993) "Increasing incidence of non-Hodgkin's lymphoma", Semin. Hematol. 286-296, 1993.
- Harris, N.L., Jaffe, E.S., Diebold, J., et al., (1999) "The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues", Ann. Oncol. 10, 1419-1432.
- Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", Am Stat. Assoc. J. 53, 457-481.
- Cox, D.R. (1972) "Regression models and life-tables", J. R. Stat. Soc. B 34, 187-220.
- McKelvey, E.M., Gottlieb, J.A., Wilson, H.E., et al., (1976) "Hydroxyldaunorubicin (adriamycin) combination chemotherapy in malignant lymphoma", Cancer 38, 1484-1493.
- Cultman, C.A., Dahlberg, S., Jones, S.E., et al. (1986) "CHOP is curative in thirty percent of patients with large-cell lymphoma: a 12-year Southwest Oncology Group (SWOG) follow-up", In: Sharin, A.T., ed. Advances in Cancer Chemotherapy Update of Treatment for Diffuse Large-cell Lymphoma (??. New York), pp 71-82.
- Klimo, P. and Connors, J.M. (1985) "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma", Ann. Intern. Med. 102, 596-602.
- Longo, D.L., De Vita, Jr. V.T., Duffey, P.L., et al., (1991) "Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial", J. Clin. Oncol. 9, 25-38.
- Skarin, A.T., Canellos, G.P., Rosenthal, D.S., et al., (1983) "Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)", J. Clin. Oncol. 1, 91-98.
- Fisher, R.I., Gaynor, E.R., Dahlberg, S., et a;., (1993) "Comparison of a standard regimen (CHOP) with three intensive regimens for advanced non-Hodgkin's lymphoma", N. Engl. J. Med. 328, 1002-1006.
- Cancer Statistics 2000(2000) "CA: a cancer", Journal for Clinicians, 7-34.
- The International Non-Hodgkin's lymphoma Prognostic Factor Project(1993) "A predictive model for aggressive non-Hodgkin's lymphoma", N. Engl. J. Med. 329, 987-994.
- Vose, J.M., Armitage, J.O., Weisenburger, D.D., et al., (1988) "The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma", J. Clin. Oncol. 6, 1838-1844.
- Gomez, H., Hidalgo, M., Casanova, L., et al., (1998) "Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis", J. Clin. Oncol. 16, 2065-2069.
- Meyer, B.M., Browman, G.P. Samosh, ML., et al., (1995) "Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma", J. Clin. Oncol. 13, 2386-2393.
- Martelli, M., Gugliehni, C., Coluzzi, S., et al., (1993) "P-VABEC: A prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodpkin's lymphoma", J. Clin Oncol. 11, 2362-2369.
- Zinzani, P.L., Storti, S., Zaccaria, A., et al., (1999) "Elderly aggressive histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients", Blood 94, 33-38.
- Meyer, R.M., Hryniuk, W.M. and Goodyear. M.D.E. (1991) "The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma", J. Clin. Oncol. 9, 339-347.
- O'Reilly, S.E., Connors, J.M., Howdle, S., et al., (1993) "In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy", J. Clin Oncol. 11, 2250- 2257.
- Sonneveld, P., de Ridder, M., van der Lelie, H., et al., (1995) "Comparison of Doxorubicin and Mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy", J. Clin. Oncol. 13, 2530-2539.
- Bjorkholm, M., Osby, F., Hagberg, H., et al., (1999) "Randomized trial of r-metHu granulocyte colony stimulating factor (G-CSF) as adjunct to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin's lymphoma", Blood 94, 2665a.
- Bezwoda, W., Rastogi, T.B., Valla, A.E., et al., (1995) "Long-term results of a multicentre randomized, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate and high-grade non-Hodgkin's lymphomas", Euro. J. Cancer 31. 903-911.
- Pavlovsky, S., Samarelli, M.T., Erazo, A., et al., (1992) "Results of a randomized study of previously untreated intermediate- and high-grade lymphoma using CHOP versus CNOP", Ann. Oncol. 3, 205-209.
CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.